CTBP1 and exocrine pancreatic carcinoma: The results showed that the effects of CTBP1-AS2 knockdown on pancreatic carcinoma cell proliferation, migration, invasion and apoptosis could be partially counteracted by inhibiting miR-141-3p (Fig. 3H-M and Fig. S1).